SCHEMBL7417684

SCHEMBL7417684

CCCNS(=O)(=O)c1ccccc1-c1ccc(C(=O)NC(CC(=O)O)C(=O)OC)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 1/20 0.44
CYP26A1 O43174 3/20 0.44
CA12 O43570 1/20 0.44
CA9 Q16790 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
GPR55 Q9Y2T6 1/20 0.43
RAB9A P51151 2/20 0.42
GAA P10253 1/20 0.42
CYCS P99999 1/20 0.42
F2 P00734 1/20 0.41
F10 P00742 1/20 0.41
PRSS1 P07477 1/20 0.41
NPC1 O15118 1/20 0.41
CA2 P00918 3/20 0.41
CA1 P00915 2/20 0.41
TAS1R3 Q7RTX0 2/20 0.40
TAS1R1 Q7RTX1 2/20 0.40
AGTR1 P30556 1/20 0.39
AGTR2 P50052 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7417679 0.86 CASP1 (0.51) CASP1CYP26A1GPR55RAB9AGAA
SCHEMBL7415012 0.86 CYP26A1 (0.46) CASP1CYP26A1RAB9AGAACYCS
SCHEMBL7423070 0.76 USP30 (0.49) RAB9AGAAF10PRSS1CA2
SCHEMBL23967346 0.75 GAA (0.54) CASP1CYP26A1L3MBTL1RAB9AGAA
SCHEMBL7464416 0.74 CA1 (0.47) CYP26A1L3MBTL1RAB9AGAAF10
SCHEMBL3632239 0.69 CA12 (0.62) CA12CA9L3MBTL1
SCHEMBL2006242 0.69 PKLR (0.56) CASP1CA12CA9L3MBTL1GAA
SCHEMBL14366117 0.69 CA12 (0.55) CA12CA9F2F10PRSS1
SCHEMBL4896298 0.68 NPC1 (0.53) CASP1CYP26A1RAB9AGAANPC1
SCHEMBL5784143 0.67 AGTR2 (0.47) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235807-A1 B-AMINO ACID-, ASPARTIC ACID- AND DIAMINOPROPIONIC-BASED INHIBITORS OF FACTOR XA Millennium Pharmaceuticals, Inc. (US) 2002-09-04 EP disclosed
WO-2001038309-A1 β-AMINO ACID-, ASPARTIC ACID- AND DIAMINOPROPIONIC-BASED INHIBITORS OF FACTOR Xa COR THERAPEUTICS, INC. (US) 2001-05-31 WO disclosed